Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping the largest market in the region, including the fast regulatory approval process in place. With value-based healthcare an increasingly hot topic, she explains how Biologix has moved to sign the first risk-sharing agreement with Saudi Arabia for a spinal muscular atrophy product; the first in the MENA region.
STAY UP TO DATE NEWS & EVENTS
Related EVENTS & NEWS
Biologix at ECTRIMS congress
Biologix has sponsored regional MS Neurologists to attend the ECTRIMS congress, for three days of back-to-back sharing, learning, and networking. Read More ...
Biologix at the International Pediatric Summit 2024
Biologix provided significant insights in the management of allergic and nephropathic cystinosis patients by sponsoring a medical symposium titled "Twice Daily Triumph: Simplifying Nephropathic Cystinosis Treatment" at the International Pediatric Summit – Revolutionary Edition IPS 2024 in Dubai.
My School Pulse - Helping children in hospitals pursue their education
